Use access key #2 to skip to page content.
$6.60 0.23 (3.58%)
10/10/2008 3:58 PM

Repros Therapeutics, Inc. (RPRX)

CAPS Rating:
*

A biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders.

View Ticker Page (RPRX)

Results 1 - 9 of 9 :   1

Recs

2

Avatar foolphighter (< 20) Submitted: 1/12/07 1:46 AM : Outperform Start Price: $12.24 RPRX Score: -8.29

Micro biotech recently announced statistically significant results for its lead drug Proellex in two different indications and non-inferiority in another drug, Androxal.

with only 10M shares o/s, and just under a $1/share in cash, a financing appear...

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar zzlangerhans (98.86) Submitted: 8/15/07 9:23 PM : Outperform Start Price: $12.68 RPRX Score: -11.27

Androxal and Proellex are likely 2008 NDA submissions. Coverage from unbiased sources is very thin, and there are potential problems with cytopathologic endometrial changes with Proellex. However, despite price near 13 market cap is only 165M which i...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar BongoBilly (63.07) Submitted: 12/27/06 7:13 AM : Outperform Start Price: $11.85 RPRX Score: -6.59

Significantly undervalued south of $25

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar sanjaymathew (< 20) Submitted: 1/23/07 1:40 AM : Outperform Start Price: $12.46 RPRX Score: -9.21

Greately undervalued relative to potential of the drugs. Excellent results so far with top class management.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Molucre (49.28) Submitted: 2/15/07 6:27 PM : Outperform Start Price: $10.95 RPRX Score: -0.33

Blockbuster drug with excellent Phase II data. Company will be bought out before the end of Phase III.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar jbfoolsgold (< 20) Submitted: 7/17/07 10:47 PM : Outperform Start Price: $13.16 RPRX Score: -7.17

Strong development pipeline, product potentials and buyout potentials. It is just a matter of time before something happens to push to $20.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar ProphetOfProfits (98.78) Submitted: 7/27/07 10:59 AM : Outperform Start Price: $13.20 RPRX Score: -10.09

Good clinical data re Proellex safety is a good enough reason for me to hop in again

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar SanDieguito (96.66) Submitted: 12/03/07 3:08 PM : Underperform Start Price: $7.65 RPRX Score: -27.18

down $2 to $7

Report this Post Replies: 1 | Reply | Permalink

Recs

0

Avatar jlmjlm77 (35.69) Submitted: 10/07/08 3:10 PM : Outperform Start Price: $6.89 RPRX Score: 9.82

Inside buying

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners